Enhancement of c-sis protooncogene transcription in bronchoalveolar mononuclear cells from patients with autoimmune diseases with lung involvement.
The expression of c-sis protooncogene in bronchoalveolar mononuclear cells has been studied in patients with autoimmune diseases with lung involvement. By nuclear run on transcription assay, we examined the transcriptional level of c-sis protooncogene in bronchoalveolar mononuclear cells from the patients. We demonstrated the enhancement of c-sis protooncogene expression in bronchoalveolar mononuclear cells from patients with autoimmune diseases with lung involvement in this study. It could suggest that the enhancement of c-sis transcription, which we first demonstrated, is involved in the existence of activated steps of bronchoalveolar mononuclear cells from patients with autoimmune diseases with lung involvement.